ALLYSA SAGGESE: Open Payments
NPI 1912448846 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$44,404 in 121 payments from 15 companies in 2025. Trend: 2023 $606 · 2024 $2,862 · 2025 $44,404
Speaker / faculty: $16,783Consulting: $15,950Food & beverage: $6,013Travel & lodging: $5,658
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 28 | $22,667 |
| Madrigal Pharmaceuticals | 40 | $12,425 |
| Gilead Sciences, Inc. | 25 | $4,641 |
| Novo Nordisk Inc | 5 | $2,447 |
| Mirum Pharmaceuticals, Inc. | 5 | $1,693 |
| Janssen Biotech, Inc. | 4 | $162 |
| ABBVIE INC. | 3 | $84 |
| Veloxis Pharmaceuticals, Inc. | 2 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| QOL Medical, LLC | 1 | $47 |
Products named: IQIRVO, REZDIFFRA, Livdelzi, Wegovy, Livmarli, TREMFYA, Vemlidy, ENVARSUS.
Industry payments across NY — which companies pay providers there.
